The biotechnology industry is seeing a broad pattern of disintegration due to the fact that big pharma companies are less and less doing which of the following core functions?
A)Infrastructure
B)Product innovation
C)Obtaining regulatory approval
D)Customer relationship
E)Manufacturing and communications

Question

Quizplus · Accepted Answer

Product innovation is increasingly being outsourced or handled by smaller, specialized biotech firms rather than being a core function of big pharma companies themselves. This shift allows big pharma to focus on other aspects like marketing, distribution, and late-stage development.

The Biotechnology Industry Is Seeing a Broad Pattern of Disintegration